Shamburg News · 8-K filed Nov 12, 2026, 4:20 PM EST

Pacira BioSciences Reports Appellate Ruling in RDF Royalty Litigation Over EXPAREL

PCRX · Pacira BioSciences, Inc.

  • Other event
  • Reg FD disclosure
  • Materiality: medium

Pacira BioSciences disclosed under Regulation FD that the Ninth Circuit Court of Appeals reversed in part the District Court's judgment in its royalty dispute with the Research Development Foundation (RDF). The appellate court held that the Company owes royalties on EXPAREL manufactured using its 200-liter process and remanded to recalculate pre-judgment interest on the 45-liter portion. The Company stated it is evaluating its legal options and is unable to predict the outcome of the action.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001140361-26-043437.

Written from the filing by Shamburg Markets. Figures are as reported by the company.